Chen Lung Tsai - 31 Dec 2025 Form 4 Insider Report for CapsoVision, Inc (CV)

Role
Director
Signature
/s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Tsai Chen Lung
Issuer symbol
CV
Transactions as of
31 Dec 2025
Net transactions value
+$30,862
Form type
4
Filing time
31 Dec 2025, 17:09:26 UTC
Previous filing
17 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tsai Chen Lung Director C/O CAPSOVISION, INC., 18805 COX AVENUE, SUITE 250, SARATOGA /s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Tsai Chen Lung 31 Dec 2025 0001307275

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CV Common Stock Options Exercise $30,862 +2,887 $10.69 2,887 31 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CV Restricted Stock Unit (RSU) Options Exercise $0 -2,887 -100% $0.000000 0 31 Dec 2025 Common Stock 2,887 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.
F2 These RSUs are scheduled to vest on December 31, 2025.